Cargando…

Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients

Greater inflammatory signaling has been shown to promote breast cancer disease progression and poorer clinical outcomes. Lower social support and social well-being have been related to greater inflammatory signaling and poorer clinical outcomes in women with non-metastatic breast cancer, and this ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis, Joaquim C., Travado, Luzia, Seixas, Elsa, Sousa, Berta, Antoni, Michael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885603/
https://www.ncbi.nlm.nih.gov/pubmed/35243410
http://dx.doi.org/10.1016/j.bbih.2022.100433
_version_ 1784660463918776320
author Reis, Joaquim C.
Travado, Luzia
Seixas, Elsa
Sousa, Berta
Antoni, Michael H.
author_facet Reis, Joaquim C.
Travado, Luzia
Seixas, Elsa
Sousa, Berta
Antoni, Michael H.
author_sort Reis, Joaquim C.
collection PubMed
description Greater inflammatory signaling has been shown to promote breast cancer disease progression and poorer clinical outcomes. Lower social support and social well-being have been related to greater inflammatory signaling and poorer clinical outcomes in women with non-metastatic breast cancer, and this appears to be independent of depression. However, little is known about these associations in women with metastatic disease. s100A8/A9 and interleukin 1 beta (IL-1β) proteins are widely studied in breast cancer and are considered as biomarkers of cancer progression or as having a causal role in carcinogenesis and cancer progression and metastasis via inflammatory signaling. The aim of this study was to examine the associations between less social/family well-being (SWB) and S100A8/A9 and IL-1β levels in women diagnosed with metastatic breast cancer. Sixty women (Mean age 58.95 ​± ​1.49) with a diagnosis of metastatic breast cancer participated in the study. The Functional Assessment of Cancer Therapy (FACT) social and family well-being (SWB) subscale and the Hospital Anxiety Depression Scale (HADS) were administered to patients undergoing a first- or second-line endocrine or oral chemotherapy treatment and who were not experiencing brain metastasis or visceral crisis. Salivary s100A8/A9 and IL-1β levels were assessed at 5PM on two consecutive days and averaged. Multiple regression tested the independent contribution of SWB on s100 A8/A9 and IL-1b while controlling for depression. Lower levels of SWB were associated with greater S100A8/A9 (ß ​= ​−0.345, p ​= ​0.007) and IL-1β (ß ​= ​−0.286, p ​= ​0.027) levels and these associations remained significant after controlling for depression. This work provides new evidence for the role of decreased SWB and greater s100A8/A9 and IL-1b levels in patients diagnosed with metastatic breast cancer. Psychosocial interventions that promote social support and positive social interactions through interpersonal skills may help metastatic breast cancer patients to improve their SWB. This may have salutary effects on cancer-promoting processes, which could provide psychological and physical health benefits.
format Online
Article
Text
id pubmed-8885603
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88856032022-03-02 Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients Reis, Joaquim C. Travado, Luzia Seixas, Elsa Sousa, Berta Antoni, Michael H. Brain Behav Immun Health Full Length Article Greater inflammatory signaling has been shown to promote breast cancer disease progression and poorer clinical outcomes. Lower social support and social well-being have been related to greater inflammatory signaling and poorer clinical outcomes in women with non-metastatic breast cancer, and this appears to be independent of depression. However, little is known about these associations in women with metastatic disease. s100A8/A9 and interleukin 1 beta (IL-1β) proteins are widely studied in breast cancer and are considered as biomarkers of cancer progression or as having a causal role in carcinogenesis and cancer progression and metastasis via inflammatory signaling. The aim of this study was to examine the associations between less social/family well-being (SWB) and S100A8/A9 and IL-1β levels in women diagnosed with metastatic breast cancer. Sixty women (Mean age 58.95 ​± ​1.49) with a diagnosis of metastatic breast cancer participated in the study. The Functional Assessment of Cancer Therapy (FACT) social and family well-being (SWB) subscale and the Hospital Anxiety Depression Scale (HADS) were administered to patients undergoing a first- or second-line endocrine or oral chemotherapy treatment and who were not experiencing brain metastasis or visceral crisis. Salivary s100A8/A9 and IL-1β levels were assessed at 5PM on two consecutive days and averaged. Multiple regression tested the independent contribution of SWB on s100 A8/A9 and IL-1b while controlling for depression. Lower levels of SWB were associated with greater S100A8/A9 (ß ​= ​−0.345, p ​= ​0.007) and IL-1β (ß ​= ​−0.286, p ​= ​0.027) levels and these associations remained significant after controlling for depression. This work provides new evidence for the role of decreased SWB and greater s100A8/A9 and IL-1b levels in patients diagnosed with metastatic breast cancer. Psychosocial interventions that promote social support and positive social interactions through interpersonal skills may help metastatic breast cancer patients to improve their SWB. This may have salutary effects on cancer-promoting processes, which could provide psychological and physical health benefits. Elsevier 2022-02-22 /pmc/articles/PMC8885603/ /pubmed/35243410 http://dx.doi.org/10.1016/j.bbih.2022.100433 Text en © 2022 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Full Length Article
Reis, Joaquim C.
Travado, Luzia
Seixas, Elsa
Sousa, Berta
Antoni, Michael H.
Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients
title Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients
title_full Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients
title_fullStr Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients
title_full_unstemmed Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients
title_short Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients
title_sort low social and family well-being is associated with greater rage ligand s100a8/a9 and interleukin-1 beta levels in metastatic breast cancer patients
topic Full Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885603/
https://www.ncbi.nlm.nih.gov/pubmed/35243410
http://dx.doi.org/10.1016/j.bbih.2022.100433
work_keys_str_mv AT reisjoaquimc lowsocialandfamilywellbeingisassociatedwithgreaterrageligands100a8a9andinterleukin1betalevelsinmetastaticbreastcancerpatients
AT travadoluzia lowsocialandfamilywellbeingisassociatedwithgreaterrageligands100a8a9andinterleukin1betalevelsinmetastaticbreastcancerpatients
AT seixaselsa lowsocialandfamilywellbeingisassociatedwithgreaterrageligands100a8a9andinterleukin1betalevelsinmetastaticbreastcancerpatients
AT sousaberta lowsocialandfamilywellbeingisassociatedwithgreaterrageligands100a8a9andinterleukin1betalevelsinmetastaticbreastcancerpatients
AT antonimichaelh lowsocialandfamilywellbeingisassociatedwithgreaterrageligands100a8a9andinterleukin1betalevelsinmetastaticbreastcancerpatients